Evading innate immunity during human cytomegalovirus latency
Evading innate immunity during human cytomegalovirus latency
批准号:
9919503
负责人:
ROBERT F KALEJTA
金额:
$35.58万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-02 至 2023-04-30
关键词:
Acquired Immunodeficiency SyndromeAffectAntiviral AgentsBrain GlioblastomaBrain NeoplasmsCD8-Positive T-LymphocytesCREB1 geneCardiovascular DiseasesCellsCommunicable DiseasesCongenital AbnormalityCytomegalovirusCytomegalovirus InfectionsCytotoxic T-LymphocytesDataDetectionDiseaseEarly PromotersElderlyEpigenetic ProcessEventGene SilencingGenesGenetic TranscriptionGenomeHIVHerpesviridaeHeterochromatinHumanImmuneImmune EvasionImmunologic SurveillanceInfectionInflammatoryInnate Immune ResponseInvadedLeadLifeLinkLysineLyticLytic PhaseMaintenanceMalignant NeoplasmsMediatingNatural ImmunityOrgan TransplantationPattern recognition receptorPersonsPhasePhosphotransferasesProteinsPublishingRoleSeriesSignal Transduction PathwayStimulusTestingTimeViralViral GenomeVirusVirus LatencyWorkactivating transcription factorcytokinedesignds-DNAfightinggene repressionhistone methylationinnate immune pathwayspathogenpathogenic viruspreventpromoterreactivation from latencyrecruitresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Innate immunity senses intracellular pathogens and induces the expression of cellular genes with
antiviral functions. Most if not all viruses encode proteins that inhibit innate immunity during productive, lytic
infections, but the role of innate immunity during viral latency is underappreciated and understudied.
Latency permits human cytomegalovirus (HCMV) to colonize its hosts for their lifetime by avoiding immune
detection and clearance. During latency, the levels of lytic (productive) phase HCMV proteins such as IE1
(Immediate Early 1) are kept extremely low (or completely absent) because the promoter that drives its
expression, the Major Immediate Early Promoter (MIEP) is transcriptionally silenced by heterochromatin.
IE1 is a transcription factor that promotes progression through the viral lytic phase and is a target of
cytotoxic T cells. Therefore, keeping IE1 protein levels low or absent protects latently infected cells from
immune surveillance and restricts reactivation events until the proper stimulus is sensed. We published that
the viral UL138 protein silences IE1 transcription during latency by inhibiting the recruitment of lysine-
specific demethylases (KDMs) to the MIEP that otherwise remove repressive epigenetic histone
methylations to activate transcription. Our preliminary data indicates this occurs, in part, through a
suppression of cellular innate immune pathways. Here we propose to determine how UL138-mediated
evasion of cellular innate immunity contributes to the establishment and maintenance of HCMV latency, with
a particular focus on viral epigenetics and the transcriptional silencing of IE1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Deciphering the cell type specific control of HCMV tegument-delivered pp71 subcellular localization
-
批准号:10176409
-
项目类别:
-
资助金额:$19.43万
-
财政年份:2020
-
负责人:ROBERT F KALEJTA
-
依托单位:
Transcriptional Control of Human Cytomegalovirus Latency
-
批准号:10370328
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2018
-
负责人:ROBERT F KALEJTA
-
依托单位:
Transcriptional Control of Human Cytomegalovirus Latency
-
批准号:9894713
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2018
-
负责人:ROBERT F KALEJTA
-
依托单位:
Transcriptional Control of Human Cytomegalovirus Latency
-
批准号:9447725
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2018
-
负责人:ROBERT F KALEJTA
-
依托单位:
Evading innate immunity during human cytomegalovirus latency
-
批准号:10392335
-
项目类别:
-
资助金额:$35.58万
-
财政年份:2018
-
负责人:ROBERT F KALEJTA
-
依托单位:
Transcriptional Control of Human Cytomegalovirus Latency
-
批准号:10132969
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2018
-
负责人:ROBERT F KALEJTA
-
依托单位:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
-
批准号:8259782
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2010
-
负责人:ROBERT F KALEJTA
-
依托单位:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
-
批准号:7984157
-
项目类别:
-
资助金额:$41.04万
-
财政年份:2010
-
负责人:ROBERT F KALEJTA
-
依托单位:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
-
批准号:8651405
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2010
-
负责人:ROBERT F KALEJTA
-
依托单位:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
-
批准号:8066409
-
项目类别:
-
资助金额:$35.99万
-
财政年份:2010
-
负责人:ROBERT F KALEJTA
-
依托单位:
Retinoblastoma (Rb) protein pathway in human cytomegalovirus infected cells
-
批准号:8459580
-
项目类别:
-
资助金额:$33.47万
-
财政年份:2010
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle
-
批准号:7846702
-
项目类别:
-
资助金额:$1.84万
-
财政年份:2009
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle
-
批准号:8278696
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle
-
批准号:8975105
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle
-
批准号:8643429
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle
-
批准号:8076297
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle
-
批准号:8774162
-
项目类别:
-
资助金额:$37.14万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle
-
批准号:7522997
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the human cytomegalovirus life cycle
-
批准号:7888289
-
项目类别:
-
资助金额:$32.31万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
Role of Daxx degradation by pp71 during the Human Cytomegalovirus life cycle
-
批准号:9180671
-
项目类别:
-
资助金额:$36.74万
-
财政年份:2008
-
负责人:ROBERT F KALEJTA
-
依托单位:
海外基金